- Research works
- 4 ▼ 64% vs 2013–17
- Citations
- 9 2.5 per fractional work
- Top-10% rate
- 3.4% record average 16.5%
- Open access
- 58% world 28%
Not ranked overall: ImCare Biotech (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does ImCare Biotech (United States) publish most on?
By volume in 2022–2025: Cancer Research and Treatments, Cancer Immunotherapy and Biomarkers, Liver Disease Diagnosis and Treatment and Hepatocellular Carcinoma Treatment and Prognosis.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Research and Treatments Biotechnology 0 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 3 Liver Disease Diagnosis and Treatment Epidemiology 0 works
- 4 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 0 works
- 5 Hepatitis C virus research Hepatology 0 works
- 6 Metastasis and carcinoma case studies Pulmonary and Respiratory Medicine 0 works
- 7 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
- 8 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
- 9 Artificial Intelligence in Healthcare Health Information Management 0 works
- 10 Scientific Computing and Data Management Information Systems and Management 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
Other research institutions in Doylestown
- BioClinica (United States)
- Doylestown Hospital
- Hepatitis B Foundation
- Delaware Valley College
- Advanced Neural Dynamics (United States)
- Baruch S. Blumberg Institute
- Fox Chase Chemical Diversity Center
- Bucks County Intermediate Unit
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.